J vs ZYME · P/E 36, $14.40B cap vs rev $76.3M
Jacobs Solutions Inc. (J) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
Jacobs Solutions Inc. (J) is a engineering & construction company listed on US.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
J does not have a complete income-statement cache yet.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
J currently screens at market cap $14.40B and trailing P/E 36.0. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the J and ZYME stock pages for the full models.
Not investment advice.